Experimental treatment slows prion disease
A new experiment has not only slowed the progression of the prion disease, scrapie, it also extended the lives of prion-infected mice
List view / Grid view
A new experiment has not only slowed the progression of the prion disease, scrapie, it also extended the lives of prion-infected mice
It has been discovered that Polo-like kinase (PLK1) guards against severe DNA damage and could help target fast-growing cancer cells.
Scientists have found a way to target and knock out a protein which is widely involved in pancreatic cancer cell growth, survival and invasion.
Researchers have discovered the mechanism behind a gateway into cells for glutamine, illuminating potential ways to prevent cancer cells from getting nutrients.
Researchers have newly found that protein CD24 acts as a defensive signal and is used by cancer cells to protect themselves.
New discovery makes it possible to design new therapies to replace alpha-synuclein's function in people with Parkinson's disease.
Scientists have created the first completely artificial protein switch that can be ‘programmed’ to modify gene expression.
An antibody has been developed to block a protein secreted by the cells surrounding ovarian and pancreatic cancer tumours.
A new study has shown that proteins derived from the oncogene, KRAS, can transfer between colon cancer cells.
The advent of in vitro culturing of neural cells has been central to driving our understanding of the nervous system.
Immune cell isolation and culture are necessary for both basic research aimed at investigating the functions of different immune cell types, and for expanding specific immune cell populations for therapeutic purposes.
A new study may provide the basis for combating malignant leukemia stem cells.
A new study shows that the activity of p38 is important in MSCs, which can localise around blood vessels.
A cellular pathway may reduce side effects and extend immunotherapy duration in patients with the most common form of liver cancer.